Resources

You are here

Frost & Sullivan Australia White Paper

Full Report Full Report (Chinese)

Frost & Sullivan Asia White Paper

Executive Summary | Full Report

Case studies

 

Feasibility and Disease Report Library

Overview of Lung cancer landscape in Asia

Overview of Lung cancer landscape in Asia

Lung cancer is one of the most common malignancies in the world, representing about 1.6 million cases annually and over 10% of all new cancers. The most well-known risk factor for lung cancer is cigarette smoking which has become endemic in Asia. Hence the prevalence of the disease in Asia has dramatically increased in the past years reaching over 720,000 patients in the countries where Novotech operates. The prognosis in Asian patients is more favourable than in Western population partially due to a higher frequency of EGFR mutations.

Click here to learn more and download the report

Overview of Obesity and Diabetes landscape in Asia

Overview of Obesity and Diabetes landscape in Asia

The prevalence of obesity, and metabolic diseases such as type 2 diabetes has increased significantly in recent years worldwide.
These conditions are endemic in most Western countries, however developing nations across Asia are now seeing a surge in cases due to aging, urbanization, and changing dietary habits. It is estimated that about 80% of the people with diabetes now live in developing countries, and mortality rates due to obesity and diabetes are higher in Asia-Pacific compared to the rest of the world.

Click here to learn more and download the report

Prostate cancer landscape in AsiaD

Prostate cancer landscape in Asia

The Asia-Pacific region has about one in six of all prostate cancer cases, and prostate cancer is the most diagnosed male cancer in China, Australia, and New Zealand. Globally, it is the second leading cause of cancer death. Developing economies of Asia-Pacific such as the Philippines and India have witnessed a sharp increase in the number of prostate cancers in the past years due to ageing population and changing dietary habits. The prevalence of the disease is estimated to have reached over 700,000 cases in the region.

Click here to learn more and download the report

Renal and Bladder cancer landscape in Asia

Renal and Bladder cancer landscape in Asia

The incidence of urological cancer has increased consistently in the recent years globally. Bladder cancer has become the ninth most common cancer worldwide, with over 400,000 new cases diagnosed each year. A majority of all bladder cancer cases occur in men in the less developed regions of the world due to environmental factors and smoking habits.

Click here to learn more and download the report

Asia Pacific, a hub for clinical trials in NAFLD

Asia Pacific, a hub for clinical trials in NAFLD

Non-alcoholic fatty liver diseases (NAFLD) are one of the most common liver disorder in developed countries and are particularly prevalent in Asian countries, especially in South Korea and Taiwan. Over a third of all industry-sponsored clinical studies initiated during the period (2015-2017) involved sites located in a country in which Novotech operates.

Click here to learn more and download the report

Liver cancer landscape in Asia

Liver cancer landscape in Asia

Hepatocellular carcinoma (HCC) and bile duct malignancies are highly prevalent in Asia, especially in South Korea and in Japan where the prevalence rate is about 5 times higher than in Western countries. Chronic viral hepatitis infections as well as fatty liver diseases (NASH in particular), which are endemic in this part of the world, are known to markedly increase the risk of developing HCC and explain the high rates observed in Asia.

Click here to learn more and download the report

Hepatitis B landscape in Asia

Hepatitis B landscape in Asia

It is estimated that at least 2 billion people or one third of the world’s population have been infected with HBV. Approximately 240 million people or 6% of the world’s population are chronically infected and the Asia Pacific region represents three quarters of chronic HBV patients worldwide.

Click here to learn more and download the report

Gastric cancer landscape in Asia

Gastric cancer landscape in Asia

Gastric Cancer malignancies are highly prevalent in Asia, especially in South Korea and in Japan where the prevalence rate is about 10 times higher than in Western countries. Diet and lifestyle such as alcohol consumption, smoking and obesity, as well as other factors such as Helicobacter pylori infections, are known to increase the risk of developing Gastric Cancer and explain the high rates of cases observed in Asia.

Click here to learn more and download the report